Phase 1b results
| Adverse outcome event | Events/1000 HPN days of service | Events/patient |
| Access device events | 0.384 | 0.09 |
| Adverse drug reactions | 0.021 | 0.07 |
| Emergency department visits | 0.277 | 0.01 |
| Unplanned hospitalisations | 3.647 | 0.87 |
| Therapy-related unplanned hospitalisations | 0.789 | 0.19 |
| Therapy unrelated unplanned hospitalisations | 2.858 | 0.68 |
| Overall adverse outcomes | 4.33 | 1.03 |
Note. Adverse outcomes in 197 long-term HPN patients at 7 study branches.
HPN, home parenteral nutrition.